Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-11-16

Clinical Trial Update: Nifedipine vs Telmisartan on Prevention of Atrial Fibrillation (AF) Recurrence in Hypertensive Patients With AF [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing nifedipine and telmisartan for prevention of atrial fibrillation recurrence in hypertensive patients with atrial fibrillation, st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nifedipine (nifedipine)
  • Telmisartan (Telmisartan)

Snippet

Sponsor: The Second Affiliated Hospital of Chongqing Medical University | Conditions: Atrial Fibrillation | Phase 4 | Status: COMPLETED